26-28 Feb, 2025
Westin Miyako KyotoKyoto, JapanDr. Xinxin Gao, PhDPrincipal Scientific Manager, Peptide Therapeutics at GenentechSpeaker
Profile
Xinxin Gao is a Principal Scientific Manager in the Peptide Therapeutics division at Genentech. He received his PhD in Chemistry from the University of Miami in 2006. After a successful postdoctoral training at the Johns Hopkins University, he joined Genentech in 2010. Xinxin now manages a group focused on developing Disulfide Constrained Peptide (DCP) binders against various therapeutic targets. He has co-authored > 30 publications in leading journals and is a co-inventor on several patents.
Agenda Sessions
Identification of Disulfide Constrained Peptide Based Binders against Membrane Bound E3 Ubiquitin Ligases
, 11:30amView Session